Martin Crook
Director/Board Member at Cardior Pharmaceuticals GmbH
Profile
Martin Crook is currently a Director at Cardior Pharmaceuticals GmbH.
He obtained a doctorate degree from the University of Bristol in 2000, an undergraduate degree from the University of Lancaster in 1995, and a graduate degree from the University of Birmingham in 1996.
Martin Crook active positions
Companies | Position | Start |
---|---|---|
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Director/Board Member | - |
Training of Martin Crook
University of Lancaster | Undergraduate Degree |
University of Birmingham | Graduate Degree |
University of Bristol | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Health Technology |
- Stock Market
- Insiders
- Martin Crook